References |
1. Fiorito J, Vendome J, Saeed F, Staniszewski A, Zhang H, Yan S, Deng SX, Arancio O, Landry DW. Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's Disease. J Med Chem. 2017 Nov 9;60(21):8858-8875. doi: 10.1021/acs.jmedchem.7b00979. Epub 2017 Oct 23. PubMed PMID: 28985058. 2. Sasseville M, Côté N, Gagnon MC, Richard FJ. Up-regulation of 3'5'-cyclic guanosine monophosphate-specific phosphodiesterase in the porcine cumulus-oocyte complex affects steroidogenesis during in vitro maturation. Endocrinology. 2008 Nov;149(11):5568-76. doi: 10.1210/en.2008-0547. Epub 2008 Jul 31. PubMed PMID: 18669600. 3. Kim DK, Lee N, Lee JY, Ryu DH, Kim JS, Lee SH, Choi JY, Chang K, Kim YW, Im GJ, Choi WS, Kim TK, Ryu JH, Kim NH, Lee K. Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues. Bioorg Med Chem. 2001 Jun;9(6):1609-16. PubMed PMID: 11408180. |